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Summary: Isolated human basilar arteries were used in this study to evaluate the inhibitory effect of an tithrombin III (AT III), thrombin, and u2-macroglobulin (U2-M) on contractions elicited by K +, serotonin (5-HT), prostaglandin (PG) Dz, PGFza, and plasmin. uz-M (0.5-1.0 mg/ml) failed to affect the contractions produced by contractile agonists significantly but did notably re duce the basal tone of the arteries. Thrombin (1 and 10 Vim!) reduced basal tone and significantly inhibited the contractions elicited by K +, PGFza, and plasmin. The re laxant effect of thrombin was abolished by procedures that destroy endothelium and by exposing the artery to thrombin for prolonged periods (tachyphylaxis). AT III Cerebral vasospasm is a phenomenon that com monly follows aneurysmal hemorrhage and results in cerebral ischemia (Fisher et al. , 1977) . The volume of blood at the site of hemorrhage is predic tive of the occurrence of severe vasospasm (Fisher et aI., 1980) . However, one enigmatic characteristic of the vasospasm is that the median time of onset is 7 days. The nature of this delayed response is un known but, among other possibilities, investigators have proposed that oxyhemoglobin from lysed erythrocytes (Sonobe and Suzuki, 1978) , or the progressive rise in fibrinolytic activity from plasmin after hemorrhage (White and Robertson, 1985) , may be responsible for the arterial constriction.
Another possibility is that blood contains proteins that, for a period of time, protect the arteries from vasospasm. In this regard, not all patients who suffer from subarachnoid hemorrhage experience cerebral vasospasm, even those at high risk (Fisher et al. , 1980) .
Recent studies have shown that the anticoagu lants antithrombin III (AT III) and az-macroglob ulin (a2-M) are vasodilators of isolated canine bas ilar arteries (White, 1986) . In contrast, the main ef fect of thrombin on the canine basilar artery is vasoconstriction (White et aI. , 1984; White and Robertson, 1985) . Because these proteins are abun dantly present in extravasated blood and are re markably stable in biological fluids, they could af fect vasomotion of cerebral arteries following aneu rysmal hemorrhage.
The present study was performed to characterize the effects of certain blood proteins on human cere bral arteries because corresponding canine vessels may react differently to vasoactive agents (Toda, 1977) and because the results would pertain more directly to the phenomenon of delayed vasospasm seen clinically.
MATERIALS AND METHODS
The basilar arteries were obtained at autopsy from 47 victims of accidents and other unnatural causes within 24 h of death. The average age was 34 ± 2.1 years (range 17-70 years). Thirty-two of these vessels were found to be normal by gross inspection, the remainder had min imal (n = 12) to moderate (n = 5) atherosclerosis. The average outside diameter was 3.59 mm. The vessels were placed in cold Krebs-Hensleit buffer at autopsy. A 4-mm segment (ring) was mounted onto two prongs, one fixed to the 10-ml tissue chamber and one movable, from which isometric contractions were recorded. Details of the tissue bath have been published (Allen et aI., 1974) . The Krebs-Henseleit buffer used in the bath had the fol lowing composition (mM):NaCl, 118.3; KCI, 4.7; MgS04, 1.2; KH2P04, 1.2; CaCI2, 2.5; NaHC03, 25; glucose, 11.0. The arterial segment was aerated with 95% O2 and 5% CO2 and kept at 37°C. The pH was 7.35.
Two tissue baths were used so that rings in duplicate could be studied. The type of experiment performed on each segment from the same individual differed, so that any peculiarity of one basilar artery could not dominate the overall findings. The passive tension initially placed on the artery was 2 g. If the vessel relaxed > 1 g in re sponse to the initial stretch (stress-relaxation), additional stretch was applied as necessary to establish a baseline tone of between 1 and 2 g. One hour later the responses elicited by 10, 30, 50, and 90 mM KCl were recorded. This was repeated every 20 min until the maximal con tractile response (CmaJ was obtained. The response to K + was used as a standard for comparing other contrac tile responses because it is independent of receptors and because of the great variation in response among isolated arteries (Allen et aI., 1974) . In this regard there was no obvious relationship between the time after death (within 24 h) and the magnitude of the response to K + .
The experimental agents used were serotonin creati nine sulfate (5-HT), prostaglandin (PG) D2, PGF2 a , plasmin, thrombin, u2-M, and AT III, all obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). The pro teins were dissolved in warm buffer and the 5-H T, PGD2, and PGF2a in water. The drug solutions and thrombin were added to the bath in 10-and 100-f.l1 volumes. Plasmin, AT III, and U2-M were dissolved in 0.5-1 ml of buffer taken from the bath and returned so that the volume of the bath was unaltered during the observation periods.
The responses elicited by each of the experimental agents were first studied separately and observed for at least 15 min. In some experiments the inhibitory protein AT III was applied after the artery contracted in the pres ence of an agonist. However, in most of the present ex periments, the inhibitory proteins were administered 5-7 min prior to the contractile agonists primarily to deter mine their effect on the phasic portion of contraction of the concentration-response curve. The rate of decay of the tonic phase varies greatly with the type of agonist used, as well as with the arterial preparation, making it more difficult to quantify and compare the inhibitory ef fect of relaxants (White and Robertson, 1985) . Cumula-tive concentration-response curves were obtained for K +, 5-HT, PGD2, and PGF2a. Some experiments were performed on basilar arteries reamed to destroy the endo thelium (White et aI., 1984) to ascertain if the vasodilative effect of the proteins depended on the release of the en dothelium-dependent relaxant factor (Furchgott, 1984) . The presence or absence of the endothelium was verified histologically with hematoxylin and eosin stain.
Responses to the agonists were expressed as means ± SEM. The level of significance of the response was as sessed by the appropriate Student t test.
RESULTS

Potassium chloride
The responses elicited by 10, 30, 50, and 90 mM K + are shown in Fig. 1 . The first trial with K + was performed after the 60-min equilibrium period. The response to K + improved with each subsequent trial until the fourth trial, after which the responses were similar « 10% change). The response was maintained for the IS-min observation period, and it was evident that after the first trial 50 mM pro duced essentially the same effect as 90 mM (Fig. 1) . The C m a x (90 mM) obtained with the 12 arteries was 8. 4 ± 1. 09 g (3. 4-17. 4 g). The experiments were carried out for from 7 to 11 h, during which time the responsiveness of the vessel was tested periodically with K + and at the end of the experiment. Only those vessels that consistently responded to K + within 10% of the initial maximum were used in the analysis of the results. About 4% of the prepara tions 'were unsatisfactory by that criterion. The basal tone on average rose gradually from 1.3 ± 0. 1 to 2.8 ± 0.3 g throughout the observation period ( � 0 . 2 I g/h) without producing demonstrable changes in the contractile responses.
Inhibition by AT III of contractile response of basilar artery
The significant inhibitory effects of AT IlI on the contractile responses elicited by 5-HT, K+, and PGF2a are summarized in Fig. 2 . In these experi ments AT III was given 5 -7 min prior to the ago nist. As shown, AT III produced a concentration dependent inhibition. The contractions induced by 5-HT were more affected by AT III than those in duced by K + and PGF2a. The average responses to K + and PGF2a were the same after washout as they were in control. Thus, the inhibitory effect of AT III was completely removed by washout. In the case of 5-HT, however, it was found that some ar teries became less responsive to 5-HT with re peated applications; these arteries were not in cluded in the analysis presented in Fig. 2 .
The C m ax (10-4 M) for 5-HT in Fig. 2 was 4. 8 ± 1. 2 g, which was 63% of that produced by K + (7. 6 ± 1.3 g). The C m ax for K + in these experiments with AT III was 6. 7 ± 0.9 g, and that for PGF2 a was 10.8 ± 1.9 g, �138% of that for K+ (7. 8 ± 0. 9 g). Figure 3 illustrates the basic effects of AT IlI on the contractile responses induced by K + and PGFz a in separate arteries (A and B). Figure 3A (left to right) shows a control response to K + and that 2 V of AT III given before K + reduced the basal tone of the artery and inhibited K + -induced contraction. Figure 3B shows, in sequence, a control response to PGF2a and the concentration-dependent inhibi- 20 0 (J tion of the response by 2 and 4 V of AT III given beforehand. It is also evident that the arteries did not escape from the inhibitory effect of AT III throughout the I5-min observation period.
Comparison of inhibitory effect of AT III with that of cx2-M Figure 4 shows that whereas AT III at concentra tions of 2-6 Vlml inhibited the contractions pro duced by PGD2 in a concentration-dependent manner, cxz-M at 0.5 and 1 mg/ml had no significant inhibitory effect on PGD2• In these experiments AT III and cx2-M were given prior to the addition of PGD2 to the bath. In other experiments cx2-M (1 mg/ml) failed to inhibit the contractile effect of K + (n = 2).
In arteries precontracted with 90 mM K + (n = 2), 10-5 M PGFZa (n = 2), 10-5 M PGDz (n = 2), and 1.0 Vlml plasmin (n = 6), AT III (2 and 4 Vlml by cumulative application) clearly inhibited the contraction. AT III was administered 10 min after the agonist and after the contraction peaked, ex cept in the case of plasmin. With plasmin AT III was given 60 min after its application because the peak contraction developed slowly, requiring on average 33. 5 ± 6. 8 min. The rate of decline in the contractile force with AT III and the sensitivity of the artery to the AT III inhibition seemed to vary greatly ( Fig. 5A and B) . Nevertheless, the average drop in contractile force was less with 2 V than with a total of 4 V. In the case of plasmin, the drop was 52. 7 ± 15. 8% with 2 V and 79. 6 ± 10.6% with 4 V. In any case 1 mg/ml cxz-M had no effect on arteries pre contracted with K + (n = 2) or plasmin (n = O.
On the other hand, when given alone cx2-M invari ably reduced the basal tone of the artery (n = 8), as shown in Fig. 5C , yet failed to influence agonist induced contractions (Figs. 4 and 5).
Comparison of vasorelaxant effect of thrombin with that of AT III
When added alone 1 U Iml thrombin decreased basal tone from an average of 2. 1 ± 0. 2 to 1.4 ± 0.2 g (n = 6). To ascertain if a higher concentration might in addition elicit constriction, 10 Dlml was added. In the absence of a constrictor response, it was found that the response to high K + was inhib ited by � 33 ± 7. 5% (n = 3). Figure 6A illustrates this inhibitory effect. When applied to arteries pre contracted with 1 U/ml plasmin (n = 2) or with 10-5 M PGF2cx (n = 6), 1 Dlml thrombin reduced the force of contraction by 26 and 30%, respec tively. In the case of PGF2cx' for instance, thrombin reduced the contraction of 9. 7 ± 2. 4 to 6. 8 ± 0. 6 g (p < 0.05). Figure 6B (1) illustrates that the vasorelaxant ef fect of thrombin (1 Dlml) peaked at � 5 min and that thereafter the artery recovered or escaped from the inhibition. Moreover, the vessel became tachyphy lactic to the dilative effect upon repeated exposure to thrombin (n = 2). Also, as shown in Fig. 6B(2) , when thrombin was applied to the artery for 90-120 min, complete tachyphylaxis was induced (n = 4). However, each artery tachyphylactic to thrombin still responded to AT III (n = 4) and failed to escape from its dilative effect even when relatively small doses (2 U/mI) of AT III were applied [ Fig.  6B(3) ]. In the tachyphylactic vessel, 2 Dlml AT III reduced the contractile force elicited by PGF2cx by �23 ± 4.4% (n = 4).
Reaming the artery to destroy the endothelium abolished the usual vasorelaxant effect of 1 and 10 U/ml thrombin in vessels precontracted with 10-5 M PGF2cx (n = 5). The minimum effect of thrombin was zero (n = 2), and the maximum reduction of the contraction was 6%, for an average of 2. 7 ± 1. 2%. In contrast, 2 U/ml AT III relaxed the reamed arteries precontracted with PGF2cx from a contraction of 10.1 ± 2.3 to 8. 3 ± 1. 4 g (p < 0.05).
DISCUSSION
These results establish that AT III is a potent di lator of human cerebral arteries and support the concept that AT III could protect arteries from the vasoconstrictor effect of agonists of diverse struc ture. The antithrombin activity in 1 ml plasma has been variously reported to be 300-700 U, which is greater than the 150-300 U of thrombin reportedly generated during coagulation. AT III accounts for 70-90% of this antithrombin activity, with the re mainder due mainly to u2-M (Bick, 1982) . More over, AT III is not thought to be consumed during coagulation (Fareed et al. , 1982) . In any case the concentration of protein used in these experiments was �0.7% (3 x 10-8 M) to 4.0% (1.8 x 10-7 M) of the concentration normally present in plasma (4.5 x 10-6 M).
The finding that AT III acts independently of the endothelium suggests that its presence in the circu lation would not affect cerebrovascular tone. In contrast, thrombin produces vasodilation both in vitro (White et al. , 1984) and in vivo (Younce et al. , 1977) by the release of an unidentified endothelium factor (Furchgott, 1984) . This thrombin effect has been used to identify functional endothelium in ce rebral arteries (Katusic et al. , 1984) . However, fem oral arteries repeatedly exposed to thrombin mani fest an incomplete tachyphylaxis to thrombin (De Mey et al. , 1982) . The present study demonstrates that in the human basilar artery, prolonged expo sure to a physiological concentration of thrombin will induce complete tachyphylaxis to its vasore laxant effect. In contrast, the dilative effect of AT III was not tachyphylactic and persisted throughout the observation period. Thus, AT III differed from thrombin by acting independently of the endothe lium and by failing to induce tachyphylaxis.
The results show further that there are important fundamental differences between the responses of human and canine basilar arteries. In the latter the predominant effect of thrombin is a prolonged con striction, not relaxation. The transient vasodilation produced by thrombin in the canine basilar artery is abolished by destruction of the endothelium, whereas the constrictor effect is not (White et al. , 1984) . It is also reported that bradykinin relaxes human basilar arteries but constricts the corre sponding canine vessel (Toda, 1977) . Differences in the vasorelaxant effect of <X2-M are also apparent. At a I-mg/ml concentration, only the basal tone was reduced in the human vessel, whereas as little as 0.1 mg/ml W30 of the human plasma value) of the protein inhibited the contractile responses of canine basal arteries to a variety of agonists (White, 1986) . It is possible that the thicker wall of the human vessel impedes the penetration of <X2-M (M W 820,000) to limit its effectiveness. Nevertheless, such differences in response indicate the impor tance of studying the human vessel as a means of elucidating factors that may influence the phenom enon of cerebral vasospasm.
Although the disposition of AT III after sub arachnoid hemorrhage is unknown, its presence in the CSF could be a factor in the phenomenon of delayed cerebral vasospasm. The nonspecific inhi bition of vascular smooth muscle demonstrated in this and previous studies (White and Robertson, 1985; White, 1986) suggests that AT III could pro tect blood vessels until it disappears from the CSF. Its presence in the CSF after hemorrhage may also account for the fact that many patients with sub arachnoid hemorrhage do not develop vasospasm.
In this regard there are isolated reports showing that the CSF of patients with subarachnoid hemor rhage may possess vasorelaxant properties (Blaso et al., 1980) and that patients may manifest cerebral vasodilation arteriographically after the hemor rhage (Kwak et al., 1979) . The vasoconstriction produced in isolated cerebral arteries by xantho chromic CSF of subarachnoid hemorrhage pa tients or hemolysates of erythrocytes is antago nized by AT III, indicating further the ubiquitous inhibition of this protein . The inhibition by AT III of the contractile effect of PGD2 was specifically studied herein because PGD2 is reported to be the main PG produced by brain and its concentration in CSF has been observed to reflect the onset and course of cerebral vasospasm (Rodriguez y Baena et al., 1985) . It is also synthe sized by cerebral arteries (Hagen et al., 1979) .
The fact that AT III inhibits the contractile re sponses to high K + further indicates that it pro duces its vasorelaxant effect through a fundamental mechanism. The mechanism is unknown, but AT III evidently does not cause release of relaxant factors from the endothelium, as is the case with many compounds (Furchgott, 1984) , nor does it stimulate the sodium pump to produce relaxation (White, 1986) . It does not produce tachyphylaxis as does vasoactive intestinal polypeptide (Toda, 1982) . Other pr9teins studied fail to possess the relaxant effect of AT III (White, 1986) , and the present work shows that U2-M is far less effective as a relaxant than AT III in the human basilar artery. Preliminary studies performed on human middle cerebral ar teries and cultured vascular smooth muscle show, respectively, that other cerebral vessels relax in the presence of AT III and that the rise in intracellular Ca 2 + produced by 50 mM K + is completely re versed by 5 U/ml AT III (A. Hassid and R. P. White, unpublished data). Further research should elucidate a mechanism of action for AT III. The present pharmacodynamic study demonstrates that AT III is a remarkably potent vasorelaxant of human cerebral arteries and suggests that the oc currence of cerebral vasospasm may depend first on the egress of AT III from the CSF after hemor rhage.
